What Are the Challenges in Developing Antitumor Agents?
Despite the promise of antitumor agents, several challenges exist in their development:
Drug resistance: Cancer cells can develop resistance to treatments, rendering them less effective over time. Toxicity: Many antitumor agents can cause significant side effects, limiting their use and tolerability. Selective targeting: Achieving specificity in targeting cancer cells without affecting healthy cells remains a major hurdle. Cost and accessibility: The high cost of developing and producing new antitumor agents can limit their availability to patients.
